back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 14:57 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,699
+742 vol $14.42 each |
180,309 | |
| Filed 2026-04-01 14:51 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-1,484 vol |
2,116 | |
| Filed 2026-03-31 12:45 Tx date 2026-03-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,470
-100 vol $14.70 each |
179,567 | |
| Older filings | ||||||
| Filed 2026-03-27 13:35 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,600 vol |
3,600 | |
| Filed 2026-03-27 13:32 Tx date 2002-06-25 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-27 13:06 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,470
-100 vol $14.70 each |
179,767 | |
| Filed 2026-03-27 13:05 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,475
-100 vol $14.75 each |
179,667 | |
| Filed 2026-03-27 13:03 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,470
+100 vol $14.70 each |
||
| Filed 2026-03-17 07:59 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,422
+291 vol $11.76 each |
179,867 | |
| Filed 2026-01-02 11:31 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,268
+571 vol $12.73 each |
179,576 | |
| Filed 2026-01-02 11:30 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,142 vol |
179,005 | |
| Filed 2025-10-02 09:18 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,554
+568 vol $11.54 each |
180,147 | |
| Filed 2025-10-02 09:17 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,137 vol |
179,579 | |
| Filed 2025-07-06 12:08 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,678
+566 vol $11.80 each |
180,716 | |
| Filed 2025-07-06 12:06 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,132 vol |
180,150 | |
| Filed 2025-05-23 16:08 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,390
-200 vol $11.95 each |
181,282 | |
| Filed 2025-05-23 16:07 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-751.59
-63 vol $11.93 each |
181,482 | |
| Filed 2025-05-23 16:06 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,185
-100 vol $11.85 each |
181,545 | |
| Filed 2025-05-22 16:42 Tx date 2025-05-22 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,350
-200 vol $11.75 each |
181,645 | |
| Filed 2025-04-01 15:47 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,277
+563 vol $11.15 each |
181,845 | |